Enteric Disease Testing Market Analysis by Share, Growth Rate, SWOT Analysis, and Forecast

The enteric disease testing market is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increasing food demand has compelled farmers, food manufacturers, and suppliers to increase the quantity and improve the quality of agricultural produce and food products. To meet the increasing food demand, global food production must increase by 70% by 2050, according to the Food and Agriculture Organization of the United Nations (FAO). The increase in global food production impacts the growth of the enteric disease testing market, with an increasing number of enteric disease controls in each step—from raw material procurement until the product reaches consumers, who look out for accredited certification when they purchase food products to ensure the safety of food.

Enteric Disease Testing Market Driver: Increase in demand for convenience foods

Busy lifestyles have slowly shifted consumer focus from traditional buying of raw food products to convenience and packaged food products, such as frozen foods and ready-to-eat (RTE) meals. For higher marketability, additives are used to enhance the organoleptic characteristics of food & beverages. Packaged products are also treated with preservatives to improve their shelf life.

The meat, poultry, and seafood food sub-segment is estimated to account for the largest market share in the food end-use segment of the enteric disease testing market over the forecast period.

The global consumption of meat and processed meat products is highly rising. Further, with expanding globalization, food products are traded, which provides scope for various processes ranging from packaging, handling, storing and transportation, leading to food infestation. All these factors lead to an increased chance of contamination of the food, due to which meat and seafood products are estimated to account for the highest market share in the market.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313

Europe is projected to be the fastest-growing market for the forecast period.

The market in this region is primarily driven by growth in the German and UK markets. It is also driven by European food policies that have been extensively emphasized by the National Reference Laboratories (NRLs) and the European Reference Laboratories (EURLs) to maintain food standards and protect consumer health. Campylobacter has been the most commonly reported food outbreak, with an increase in confirmed human cases in the European Union (EU). The market is further fueled by the presence of major enteric disease testing companies such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), and Intertek Group plc (UK), which are continuously investing and collaborating for the development of better and faster testing technologies to aid conformity to various enteric disease regulations.

Enteric Disease Testing Market Share

Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Bureau Veritas (France), Intertek (UK), Romer Labs (Austria), Mérieux NutriSciences (US), TÜV SÜD (Germany), PerkinElmer, Inc. (US), Becton Dickinson (US), Certified Laboratories (US), ALS Limited (Australia), Neogen Corporation (US), Hardy Diagnostics (US)

Enteric Disease Testing Market Growth Opportunities by 2026

The global enteric disease testing market is estimated to be USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The growth in the enteric disease testing market is attributed to the enforcement of stringent food safety regulations and effective monitoring of the same by the regulatory authority, increasing level of consumer awareness on food safety and availability of rapid technology with low turnaround time. Lack of infrastructural facilities, high cost of replacement parts, and lack of harmonization act as major restraints for the enteric disease testing market.

 

 

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313

 

The enteric disease testing market is dominated by few globally established players such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia) and TÜV SÜD (Germany). These players have adopted growth strategies such as acquisitions, new product launches, and agreements to strengthen their presence in the global market.

 

SGS SA is engaged in the inspection, verification, testing, certification, and quality assurance services. The company has nine business segments—consumer & retail; agriculture food & life; oil, gas & chemical; minerals; industrial; government & institution; transportation; certification & business enhancement; and environmental health & safety. It offers enteric disease testing through its agriculture food & life segment. The company operates through a network of more than 2,400 offices and laboratories across Europe, the Middle East, the Americas, Africa, and the Asia Pacific. The company focuses on acquisitions and expansions as its key development strategy to maintain its market leader position and to strengthen its business in different segments. On June 2021, SGS announced the official opening of Its new food testing laboratory in Papua New Guinea, which would offer internationally recognized quality food testing manufacturing, hospitality, and retail market segments. There are many emerging opportunities, which are creating more competitors to the company such as, Eurofins (Luxembourg), Intertek (UK), and Bureau Veritas (France), among others.

 

Eurofins is an international group of laboratories that provide testing and support services to the pharmaceutical, food, environmental, agricultural, and consumer products industries and governments. The company capitalizes on a portfolio of 150,000 reliable analytical methods that enable it to offer services that characterize the safety, identity, purity, composition, authenticity, and origin of products & biological substances. It offers testing services through the following 13 divisions—food & feed testing, biopharma services, agroscience services, agro testing, clinical diagnostics, cosmetics testing, consumer product testing, forensic services, environmental testing, genomic services, medical devices, Eurofins technologies, and REACH services. It offers enteric disease testing services under its food & feed testing division.

 

Eurofins Scientific operates through 800 laboratories in 50 countries, and with such a strong global presence, the company can launch customized solutions for their customers hence the company is identified as a strong player in the enteric disease testing market. The company’s business expansion continues to expand in North America and Europe, along with the focus on expanding and optimizing its laboratory network in the Asia Pacific region. The acquisition of Covance Food Solutions (US) in 2018 allowed the company to strengthen its geographic presence in the North American market.

 

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139763313

 

The high level of awareness about healthy foods and nutrition is projected to drive the market growth for enteric disease testing market in North American region. Furthermore, the US and Canada combined have a high concentration of market players after Europe and are also high on technology adoption.

Enteric Disease Testing Market Will Hit Big Revenues In Future

The report "Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region - Global Forecast to 2026", The market for enteric disease testing is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increase in global food production impacts the food enteric disease testing market growth by increasing the number of food safety controls in each step from raw material procurement till the product reaches the consumers. Further, food manufacturers are willing to pay for testing and certification and have included this practice in their manufacturing cycles. With consumers becoming increasingly aware about the food and water-borne illnesses and stringent regulations to meet international standards, there is growing demand for enteric disease testing market.

 

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313

 

Salmonella pathogen is estimated to account for the largest market share in the by pathogen for enteric disease testing market.

 

Increasing instances of food contamination and foodborne poisoning are the major reasons for the growth of the enteric disease testing market. Pathogens such as Salmonella are highly occurring contaminants in cereals & grains and are also known as enteric bacteria often caused by birds or rodents during harvesting. Salmonella also causes contamination in meat, poultry, fruits, and vegetables. A several number of cases are found for diarrhea and cholera, resulting in several deaths caused by Salmonella infected food. These factors are paving way for growth of testing for Salmonella within the enteric disease testing market.

 

By technology, the rapid testing technology sub-segment is estimated to account for the fastest growth in the enteric disease testing market.

 

The rapid technology market has been proved as a driver for the enteric disease testing market owing to the attributes such as low turnaround time, higher accuracy, sensitivity, and ability to test a wide range of contaminants in comparison to traditional technology. Increasing food trade across borders, rising food consumption, changing lifestyles of consumers, and demand for convenience & processed food have led to the growing demand for enteric disease testing in countries around the world, especially in the booming markets of Europe.

 

The meat, poultry and seafood sub-segment by end use is estimated to account for the largest market share of enteric disease testing market over the forecast period.

 

The meat, poultry, and seafood segment is estimated to dominate the enteric disease testing market in 2021. Due to easy susceptibility to microbial and other contaminations along with the growing number of tests for meat, poultry, seafood products has resulted in the growth of the market. Stringent government policies & regulations for meat, poultry, and seafood products and assurance of safe meat to consumers have led to consistent enteric disease testing with checkpoints at different stages to eliminate any incidences of meat contamination.

 

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139763313

 

Europe is projected to be the fastest-growing market for the forecast period.

 

The market in this region is primarily driven by growth in the German and UK markets. It is also driven by European food policies that have been extensively emphasized by the National Reference Laboratories (NRLs) and the European Reference Laboratories (EURLs) to maintain food standards and protect consumer health. Campylobacter has been the most commonly reported food outbreak, with an increase in confirmed human cases in the European Union (EU). The market is further fueled by the presence of major enteric disease testing companies such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), and Intertek Group plc (UK), which are continuously investing and collaborating for the development of better and faster testing technologies to aid conformity to various enteric disease regulations.

Enteric Disease Testing Market Growth by Emerging Trends, Analysis, & Forecast

The report "Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region - Global Forecast to 2026", The market for enteric disease testing is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increase in global food production impacts the food enteric disease testing market growth by increasing the number of food safety controls in each step from raw material procurement till the product reaches the consumers. Further, food manufacturers are willing to pay for testing and certification and have included this practice in their manufacturing cycles. With consumers becoming increasingly aware about the food and water-borne illnesses and stringent regulations to meet international standards, there is growing demand for enteric disease testing market.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313

Salmonella pathogen is estimated to account for the largest market share in the by pathogen for enteric disease testing market.

Increasing instances of food contamination and foodborne poisoning are the major reasons for the growth of the enteric disease testing market. Pathogens such as Salmonella are highly occurring contaminants in cereals & grains and are also known as enteric bacteria often caused by birds or rodents during harvesting. Salmonella also causes contamination in meat, poultry, fruits, and vegetables. A several number of cases are found for diarrhea and cholera, resulting in several deaths caused by Salmonella infected food. These factors are paving way for growth of testing for Salmonella within the enteric disease testing market.

By technology, the rapid testing technology sub-segment is estimated to account for the fastest growth in the enteric disease testing market.

The rapid technology market has been proved as a driver for the enteric disease testing market owing to the attributes such as low turnaround time, higher accuracy, sensitivity, and ability to test a wide range of contaminants in comparison to traditional technology. Increasing food trade across borders, rising food consumption, changing lifestyles of consumers, and demand for convenience & processed food have led to the growing demand for enteric disease testing in countries around the world, especially in the booming markets of Europe.

The meat, poultry and seafood sub-segment by end use is estimated to account for the largest market share of enteric disease testing market over the forecast period.

The meat, poultry, and seafood segment is estimated to dominate the enteric disease testing market in 2021. Due to easy susceptibility to microbial and other contaminations along with the growing number of tests for meat, poultry, seafood products has resulted in the growth of the market. Stringent government policies & regulations for meat, poultry, and seafood products and assurance of safe meat to consumers have led to consistent enteric disease testing with checkpoints at different stages to eliminate any incidences of meat contamination.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139763313

Europe is projected to be the fastest-growing market for the forecast period.

The market in this region is primarily driven by growth in the German and UK markets. It is also driven by European food policies that have been extensively emphasized by the National Reference Laboratories (NRLs) and the European Reference Laboratories (EURLs) to maintain food standards and protect consumer health. Campylobacter has been the most commonly reported food outbreak, with an increase in confirmed human cases in the European Union (EU). The market is further fueled by the presence of major enteric disease testing companies such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), and Intertek Group plc (UK), which are continuously investing and collaborating for the development of better and faster testing technologies to aid conformity to various enteric disease regulations.

Key Market Players:

Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TÜV SÜD (Germany). Key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities along with strong distribution networks across these regions.

Enteric Disease Testing Market to Witness Unprecedented Growth in Coming Years

The enteric disease testing market is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increasing food demand has compelled farmers, food manufacturers, and suppliers to increase the quantity and improve the quality of agricultural produce and food products. To meet the increasing food demand, global food production must be increased by 70% by 2050, according to the Food and Agriculture Organization of the United Nations (FAO). The increase in global food production impacts the growth of the enteric disease testing market with an increasing number of enteric disease controls in each step—from the raw material procurement till the product reaches consumers, who look out for accredited certification when they purchase food products to ensure the safety of food.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313

COVID-19 Impact on the Global Enteric disease testing Market

The concern among consumers is estimated to increase for the security and safety of food products due to the outbreak of COVID-19, and this might lead to a high adoption rate for testing technologies and laboratories across the globe. Thus, the demand for enteric disease testing will increase in the coming years. Moreover, pandemic situations created due to the outbreak of COVID-19 will increase the demand for rapid tests from food manufacturers and growers to test an adequate number of samples in less time, thereby increasing the supply chain activities and enhancing the adoption of testing technologies.

Driver: Increase in demand for convenience foods

Busy lifestyles have slowly shifted consumer focus from traditional buying of raw food products to convenience and packaged food products, such as frozen foods and ready-to-eat (RTE) meals. For higher marketability, additives are used to accentuate the organoleptic characteristics of food & beverages. Packaged products are also added with preservatives to improve their shelf life. With the increase in preference for convenience foods, the need for enteric disease testing is growing.

Restraint: Lack of proper regulations governing pathogen testing in the developing economies

The food industry in developing countries remains highly fragmented and is predominated by small and unorganized players, who may have not necessarily adopted proper food testing practices, leading to a greater risk of contamination. The testing of food & beverage products, such as packaged foods, dairy products, beverages, and meat products, requires proper enforcement measures, coordination between market stakeholders, and supporting infrastructure. However, many countries that are classified in the cluster of developing economies lack these factors, acting as a restraint to the testing of pathogens in food and water in these regions.

The food segment is estimated to account for the fastest growth in the by end use segment for the enteric disease testing market.

The increase in food trade has encouraged public health and government agencies to continuously monitor food quality and take prompt actions to identify, contain, and correct sources of outbreaks. For instance, the Enteric disease and Inspection Service (FSIS) has framed regulations to control the contamination of meat & poultry products in slaughterhouses and processing plants, based on the HACCP enteric disease control system.

By technology, the rapid technology segment is estimated to account for the largest market share in the enteric disease testing market.

Rapid technology in the food industry is used to monitor the count, type, and metabolites of microorganisms that lead to food spoilage, preservation, fermentation, safety, and foodborne pathogens As the use of the Hazard Analysis & Critical Control Points (HACCP) model and other enteric disease systems have become firmly entrenched in quality assurance/quality control (QA/QC) programs, the industry’s need for “faster, better, cheaper” real-time test results has also increased.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139763313

The rising health awareness among consumers in the North American region and presence of key players is projected to account for the largest market size during the forecast period

The high level of awareness about healthy foods and nutrition is projected to drive the market growth for enteric disease testing market in North American region. Furthermore, the US and Canada combined have a high concentration of market players after Europe and are also high on technology adoption.

Key Market Players:

Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TÜV SÜD (Germany). Key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities along with strong distribution networks across these regions.

Enteric Disease Testing Market to Witness Unprecedented Growth in Coming Years

The enteric disease testing market is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increasing food demand has compelled farmers, food manufacturers, and suppliers to increase the quantity and improve the quality of agricultural produce and food products. To meet the increasing food demand, global food production must be increased by 70% by 2050, according to the Food and Agriculture Organization of the United Nations (FAO). The increase in global food production impacts the growth of the enteric disease testing market with an increasing number of enteric disease controls in each step—from the raw material procurement till the product reaches consumers, who look out for accredited certification when they purchase food products to ensure the safety of food.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313

COVID-19 Impact on the Global Enteric disease testing Market

The concern among consumers is estimated to increase for the security and safety of food products due to the outbreak of COVID-19, and this might lead to a high adoption rate for testing technologies and laboratories across the globe. Thus, the demand for enteric disease testing will increase in the coming years. Moreover, pandemic situations created due to the outbreak of COVID-19 will increase the demand for rapid tests from food manufacturers and growers to test an adequate number of samples in less time, thereby increasing the supply chain activities and enhancing the adoption of testing technologies.

Restraint: Lack of proper regulations governing pathogen testing in the developing economies

The food industry in developing countries remains highly fragmented and is predominated by small and unorganized players, who may have not necessarily adopted proper food testing practices, leading to a greater risk of contamination. The testing of food & beverage products, such as packaged foods, dairy products, beverages, and meat products, requires proper enforcement measures, coordination between market stakeholders, and supporting infrastructure. However, many countries that are classified in the cluster of developing economies lack these factors, acting as a restraint to the testing of pathogens in food and water in these regions.

Opportunity: Technological innovations in the enteric disease testing industry

Technological advancements and innovation across the supply chain have brought about a change in the way business is conducted. The focus is on reducing the lead time, sample utilization, the overall cost of testing services offered. Cheaper, faster, and efficient computing hardware coupled with improved software, network connectivity, and advanced sensors is gaining traction in the enteric disease industry.

By technology, the rapid technology segment is estimated to account for the largest market share in the enteric disease testing market.

Rapid technology in the food industry is used to monitor the count, type, and metabolites of microorganisms that lead to food spoilage, preservation, fermentation, safety, and foodborne pathogens As the use of the Hazard Analysis & Critical Control Points (HACCP) model and other enteric disease systems have become firmly entrenched in quality assurance/quality control (QA/QC) programs, the industry’s need for “faster, better, cheaper” real-time test results has also increased.

The meat, poultry and seafood food sub-segment is estimated to account for the largest market share in the by food end use segment of enteric disease testing market over the forecast period.

The global consumption of meat and processed meat products is highly rising. Further, with expanding globalization, food products are traded, which provides scope for various processes ranging from packaging, handling, storing and transportation, leading to food infestation. All these factors lead to an increased chance of contamination of the food, due to which the meat and seafood products are estimated to account for the highest market share in the market.

Make an Inquiry:

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=139763313

The rising health awareness among consumers in the North American region and presence of key players is projected to account for the largest market size during the forecast period

The high level of awareness about healthy foods and nutrition is projected to drive the market growth for enteric disease testing market in North American region. Furthermore, the US and Canada combined have a high concentration of market players after Europe and are also high on technology adoption.

Key Market Players:

Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TÜV SÜD (Germany). Key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities along with strong distribution networks across these regions.

Latest Regulatory Trends Impacting the Enteric Disease Testing Market

The report "Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region - Global Forecast to 2026", The market for enteric disease testing is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increase in global food production impacts the food enteric disease testing market growth by increasing the number of food safety controls in each step from raw material procurement till the product reaches the consumers. Further, food manufacturers are willing to pay for testing and certification and have included this practice in their manufacturing cycles. With consumers becoming increasingly aware about the food and water-borne illnesses and stringent regulations to meet international standards, there is growing demand for enteric disease testing market.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313

Salmonella pathogen is estimated to account for the largest market share in the by pathogen for enteric disease testing market.

Increasing instances of food contamination and foodborne poisoning are the major reasons for the growth of the enteric disease testing market. Pathogens such as Salmonella are highly occurring contaminants in cereals & grains and are also known as enteric bacteria often caused by birds or rodents during harvesting. Salmonella also causes contamination in meat, poultry, fruits, and vegetables. A several number of cases are found for diarrhea and cholera, resulting in several deaths caused by Salmonella infected food. These factors are paving way for growth of testing for Salmonella within the enteric disease testing market.

By technology, the rapid testing technology sub-segment is estimated to account for the fastest growth in the enteric disease testing market.

The rapid technology market has been proved as a driver for the enteric disease testing market owing to the attributes such as low turnaround time, higher accuracy, sensitivity, and ability to test a wide range of contaminants in comparison to traditional technology. Increasing food trade across borders, rising food consumption, changing lifestyles of consumers, and demand for convenience & processed food have led to the growing demand for enteric disease testing in countries around the world, especially in the booming markets of Europe.

The meat, poultry and seafood sub-segment by end use is estimated to account for the largest market share of enteric disease testing market over the forecast period.

The meat, poultry, and seafood segment is estimated to dominate the enteric disease testing market in 2021. Due to easy susceptibility to microbial and other contaminations along with the growing number of tests for meat, poultry, seafood products has resulted in the growth of the market. Stringent government policies & regulations for meat, poultry, and seafood products and assurance of safe meat to consumers have led to consistent enteric disease testing with checkpoints at different stages to eliminate any incidences of meat contamination.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139763313

Europe is projected to be the fastest-growing market for the forecast period.

The market in this region is primarily driven by growth in the German and UK markets. It is also driven by European food policies that have been extensively emphasized by the National Reference Laboratories (NRLs) and the European Reference Laboratories (EURLs) to maintain food standards and protect consumer health. Campylobacter has been the most commonly reported food outbreak, with an increase in confirmed human cases in the European Union (EU). The market is further fueled by the presence of major enteric disease testing companies such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), and Intertek Group plc (UK), which are continuously investing and collaborating for the development of better and faster testing technologies to aid conformity to various enteric disease regulations.

Key Market Players:

Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TÜV SÜD (Germany). Key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities along with strong distribution networks across these regions.